Home/ViewsML Technologies/Kenneth To, PhD, MBA

KT

Kenneth To, PhD, MBA

Chief Executive Officer

ViewsML Technologies

Therapeutic Areas

ViewsML Technologies Pipeline

Drug	Indication	Phase
Virtual HER2 IHC	Breast and Gastric Cancer	Service Offering
Virtual PD‑L1 IHC	Non‑Small Cell Lung Cancer	Service Offering

Leadership Team at ViewsML Technologies

Keith Jalbert, BBA

Chief Commercial Officer

Christopher Jackson, MD, MEng

Chief Scientific Officer

George Hennen, MBA, CISM

Chief Technology Officer

Rafay Azhar, MD

Medical Director

View full ViewsML Technologies profile